Type 1 Diabetes in Adolescence: Clinical Trials

3 trials for Type 1 Diabetes in Adolescence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 2 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Type 1 Diabetes in Adolescence: new trials by email Literature Review of Type 1 Diabetes in Adolescence trials Research Report on Type 1 Diabetes in Adolescence

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Implementation Trial of Implementation Toolkits for Diabetes Coaching
Base Implementation Toolkit (BIT), BIT-Enhanced, BIT-Sustainment - Implementation Science, Type 1 Diabetes in Adolescence
Not applicableRecruitingNemours Children's Clinic152026-08-262026-08-27
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
CNP-103, Placebo - Type 1 Diabetes Mellitus, T1D
Phase 1 / Phase 2RecruitingCOUR Pharmaceutical Development Company, Inc.722025-05-122026-09-11
Needs Assessment of Mediterranean Adolescents With Type 1 Diabetes About Therapeutic Education Sessions
education programs - Type 1 Diabetes in Adolescence
Not applicableCompletedAssistance Publique Hopitaux De Marseille402017-02-042022-11-17

Narrower conditions

Diabetes Mellitus, Type 1 (2)  ·  Diabetes Mellitus (1)

Broader conditions

Autoimmune Diseases (2)  ·  Endocrine System Diseases (2)  ·  Glucose Metabolism Disorders (2)  ·  Immune System Diseases (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Diabetes Mellitus (1)

Interventions

Therapeutics (1)

Sponsors

Assistance Publique Hopitaux De Marseille (1)  ·  COUR Pharmaceutical Development Company, Inc. (1)  ·  Nemours Children's Clinic (1)

Countries

United States (2)  ·  France (1)

Top investigators

Paul Peloso, MD (1)

NIH funding

K23DK125666 (1)